PocDoc has been chosen by Roche Diagnostics to participate in the acclaimed Startup Creasphere programme, which will pilot the firm’s cardiovascular diagnostics.
PocDoc's technology combines lateral flow tests and cloud-based AI diagnostics, facilitating a comprehensive cardiovascular disease assessment, diagnosis and treatment pathway. This innovation is directed towards making diagnostic testing as accessible and quick as possible, which aligns strongly with the aims of the Startup Creasphere programme. The new collaboration will explore innovative pilots, integrating PocDoc into Roche Diagnostics' broader POC ecosystem.
"We are immensely thrilled and honoured to work closely with an illustrious organisation like Roche Diagnostics through the Creasphere programme. This innovation collaboration not only elevates PocDoc's endeavours in advancing healthcare solutions but also represents a mutual commitment towards revolutionising healthcare practices," commented Steve Roest, CEO and Co-Founder of PocDoc.
Startup Creasphere, powered by Plug and Play, established by Roche and Plug and Play in 2018, serves as the inaugural health-focused innovation programme. This programme is fundamentally designed to facilitate the acceleration of success for young, innovative health technology companies through a dedicated pilot-driven programme spanning three months.